Effects of Early Stepping Verticalization + FES on CIP
1 other identifier
observational
39
1 country
1
Brief Summary
Background: Intensive Care Unit (ICU) survivors often develop an acquired weakness due to a Critical Illness Polyneuropathy (CIP). Early mobilization in ICU, by reducing the bed rest and decreasing the oxidative stress, was shown to represent a valid preventive option. Purpose: To evaluate whether ICU sessions of stepping verticalization associated with Functional Electrical Stimulation (FES) of the lower limbs are able to reduce the occurrence of CIP in Acquired Brain Injured (ABI) patients. Methods: all the ABI patients admitted in our Neurorehabilitation Unit from our ICU were retrospectively evaluated. Patients affected by previous peripheral neuropathy, diabetes, cancer, alcoholism, viral hepatitis, AIDS and autoimmune diseases were excluded. They were divided into 3 groups according to the rehabilitation strategy received in ICU: group 1 received conventional physiotherapy + stepping verticalization sessions with Erigo® (Hocoma, Switzerland); group 2 received conventional physiotherapy + stepping verticalization sessions with FES using ErigoPro®; group 3 received only conventional physiotherapy. As for internal protocol, all patients started rehabilitation in the first week from the ABI and performed 60 minutes/day of rehabilitation, 5 days/week. Primary outcome was the evidence of CIP at Neurorehabilitation admission (=ICU discharge), according to neurophysiological criteria. Secondary outcomes were the strength impairment at Neurorehabilitation discharge, measured by the total Motricity Index score and the Functional Ambulation Classification (FAC) score, assessing quality of gait.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedFirst Submitted
Initial submission to the registry
July 31, 2018
CompletedFirst Posted
Study publicly available on registry
August 6, 2018
CompletedAugust 14, 2018
August 1, 2018
1 month
July 31, 2018
August 11, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
CIP occurrence
Presence of critical illness polyneuropathy at the end of ICU stay
at enrollment
Secondary Outcomes (2)
motricity index
at enrollment
Functional Ambulation Classification (FAC)
at enrollment
Study Arms (3)
stepping verticalization
in ICU they received conventional physiotherapy + stepping verticalization sessions with Erigo
stepping verticalization + FES
in ICU they received conventional physiotherapy + stepping verticalization sessions with FES using ErigoPro
conventional physiotherapy
in ICU they received only conventional physiotherapy
Interventions
patients hospitalized in ICU are rehabilitated using 30 minutes/day of conventional physiotherapy + 30 minutes/day of verticalization using a tilt table with an integrated robotic stepping device synchronized with an electrical stimulation of the lower limbs muscles
patients receive 30 minutes/day of conventional physiotherapy + 30 minutes7day of verticalization using a tilt table with a robotic stepping device
patients are treated only with 60 minutes/day of conventional physiotherapy
Eligibility Criteria
patients hospitalized in ICU and transferred in Neurorehab after an acute brain injury
You may qualify if:
- arriving directly from our acute care facility
- hospitalized in ICU due to an acute brain injury
You may not qualify if:
- previous peripheral neuropathies
- diabetes
- cancer
- alcoholism
- viral hepatitis
- AIDS
- autoimmune diseases
- absence of clinical or neurophysiological informations at data collection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ospedale Generale di Zona Moriggia Pelascini
Gravedona, CO, 22015, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2018
First Posted
August 6, 2018
Study Start
June 1, 2018
Primary Completion
July 1, 2018
Study Completion
July 1, 2018
Last Updated
August 14, 2018
Record last verified: 2018-08